Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

scientific article published on 25 October 2017

Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00125-017-4463-4
P698PubMed publication ID29067486

P50authorLutz HeinemannQ65055050
Richard M BergenstalQ90594281
P2093author name stringAnne L Peters
Reinhard W Holl
John R Petrie
G Alexander Fleming
P2860cites workContinuous glucose monitoring systems for type 1 diabetes mellitusQ24203866
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and [...]Q28071499
Continuous Glucose Monitoring: A Review of Successes, Challenges, and OpportunitiesQ28076888
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportQ30276532
Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in DiabetesQ30276764
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveQ30276768
The evidence base for diabetes technology: appropriate and inappropriate meta-analysisQ30409804
Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis.Q33308776
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient dataQ33954163
Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetesQ34856962
Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trialsQ35337121
The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitusQ35337585
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registryQ35360823
Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetesQ35620189
Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing KetosisQ35769485
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose MonitoringQ36475919
IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very BeneficialQ36535939
Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus.Q36605704
Reimbursement for continuous glucose monitoring: a European view.Q36605855
The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and OlderQ37054706
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).Q37275395
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled TrialQ37639313
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effectsQ37671448
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.Q38025029
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical TrialQ38381853
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes TechnoQ38382412
Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trialQ38443982
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trialQ38820633
Discrepancies Between Blood Glucose and Interstitial Glucose-Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic TargetQ38891664
Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice GuidelineQ38944771
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesQ39016044
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.Q39376348
Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During ExerciseQ39645480
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).Q41196180
Now Is the Time for a Cybersecurity Standard for Connected Diabetes DevicesQ42390675
CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose MonitoringQ43145838
Physiological differences between interstitial glucose and blood glucose measured in human subjectsQ44526994
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 DiabetesQ45112208
Continuous glucose monitoring: an Endocrine Society Clinical Practice GuidelineQ46114434
Continuous glucose monitoring and intensive treatment of type 1 diabetesQ46380752
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetesQ46431323
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 DiabetesQ46659616
Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, thQ47825623
Threshold-based insulin-pump interruption for reduction of hypoglycemia.Q50888948
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.Q51107301
A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine.Q51356590
SPECTRUM.Q52848808
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).Q53339287
Patient-reported outcomes and continuous glucose monitoring: can we do better with artificial pancreas devices?Q87177705
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENTQ87234935
P433issue12
P304page(s)2319-2328
P577publication date2017-10-25
P1433published inDiabetologiaQ5270140
P1476titleImproving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
P478volume60

Reverse relations

cites work (P2860)
Q64985848Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.
Q93107710Continuous Glucose Monitoring: A Review of Available Systems
Q61805812Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System
Q90641133Evaluating a Glucose-Sensor-Based Tool to Help Clinicians and Adults With Type 1 Diabetes Improve Self-Management Skills
Q89477060Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes
Q101043636Improved estimation of glycated hemoglobin with continuous glucose monitoring and past glycated hemoglobin data

Search more.